Allakos Inc.(ALLK)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ALLK Allakos Inc.

交易中 07-23 15:55:33 EDT

0.8305

+0.0766

+10.16%

最高0.8684	最低0.7600	成交量84.70万
今开0.7600	昨收0.7539	日振幅14.38%
总市值7,354万	流通市值4,921万	总股本8,854万
成交额69.93万	换手率1.43%	流通股本5,926万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ALLK","market":"US","secType":"STK","nameCN":"Allakos Inc.","latestPrice":0.8305,"timestamp":1721764529035,"preClose":0.7539,"halted":0,"volume":847025,"delay":0,"floatShares":59258849,"shares":88544474,"eps":-2.461413,"marketStatus":"交易中","marketStatusCode":2,"change":0.0766,"latestTime":"07-23 15:55:33 EDT","open":0.76,"high":0.8684,"low":0.76,"amount":699272.6101882501,"amplitude":0.143786,"askPrice":0.8306,"askSize":300,"bidPrice":0.8304,"bidSize":300,"shortable":3,"etf":0,"ttmEps":-2.461413,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1721764800000},"adr":0,"listingDate":1531972800000,"adjPreClose":0.7539,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":0.7907,"preClose":0.7539,"latestTime":"19:55 EDT","volume":906,"amount":701.459,"timestamp":1721692549961},"volumeRatio":2.5903,"impliedVol":1.1867,"impliedVolPercentile":0.4563},"requestUrl":"/m/hq/s/ALLK","defaultTab":"news","newsList":[{"id":"2453037333","title":"Allakos Inc.盘中异动 急速上涨8.61%报0.819美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453037333","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453037333?lang=zh_cn&edition=full","pubTime":"2024-07-23 21:31","pubTimestamp":1721741519,"startTime":"0","endTime":"0","summary":"北京时间2024年07月23日21时31分，Allakos Inc.股票出现波动，股价快速拉升8.61%。截至发稿，该股报0.819美元/股，成交量1.5794万股，换手率0.02%，振幅7.80%。Allakos Inc.股票所在的生物技术行业中，整体跌幅为0.12%。Allakos Inc.公司简介：Allakos Inc是一家临床阶段的公司，开发选择性靶向存在于涉及过敏、炎症和增殖性疾病的免疫效应细胞表面的免疫调节受体的治疗性抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723213159955331a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723213159955331a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALLK","BK4139"],"gpt_icon":0},{"id":"2453714470","title":"Allakos Inc.盘中异动 大幅上涨6.22%报0.732美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453714470","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453714470?lang=zh_cn&edition=full","pubTime":"2024-07-23 02:55","pubTimestamp":1721674545,"startTime":"0","endTime":"0","summary":"北京时间2024年07月23日02时55分，Allakos Inc.股票出现波动，股价急速拉升6.22%。截至发稿，该股报0.732美元/股，成交量27.0116万股，换手率0.31%，振幅6.80%。Allakos Inc.股票所在的生物技术行业中，整体涨幅为0.94%。Allakos Inc.公司简介：Allakos Inc是一家临床阶段的公司，开发选择性靶向存在于涉及过敏、炎症和增殖性疾病的免疫效应细胞表面的免疫调节受体的治疗性抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407230255459681ef16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407230255459681ef16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALLK","BK4139"],"gpt_icon":0},{"id":"2452476457","title":"Allakos Inc.盘中异动 早盘快速拉升6.05%报0.795美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452476457","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452476457?lang=zh_cn&edition=full","pubTime":"2024-07-19 21:32","pubTimestamp":1721395924,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日21时32分，Allakos Inc.股票出现波动，股价快速拉升6.05%。截至发稿，该股报0.795美元/股，成交量2603股，换手率0.00%，振幅6.05%。Allakos Inc.股票所在的生物技术行业中，整体涨幅为0.48%。Allakos Inc.公司简介：Allakos Inc是一家临床阶段的公司，开发选择性靶向存在于涉及过敏、炎症和增殖性疾病的免疫效应细胞表面的免疫调节受体的治疗性抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407192132059f6bed16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407192132059f6bed16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALLK","BK4139"],"gpt_icon":0},{"id":"2452321634","title":"Allakos Inc.盘中异动 下午盘股价大跌5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452321634","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452321634?lang=zh_cn&edition=full","pubTime":"2024-07-19 01:00","pubTimestamp":1721322013,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日01时00分，Allakos Inc.股票出现异动，股价快速下挫5.28%。截至发稿，该股报0.780美元/股，成交量15.8935万股，换手率0.18%，振幅4.88%。Allakos Inc.股票所在的生物技术行业中，整体跌幅为1.36%。Allakos Inc.公司简介：Allakos Inc是一家临床阶段的公司，开发选择性靶向存在于涉及过敏、炎症和增殖性疾病的免疫效应细胞表面的免疫调节受体的治疗性抗体。AK006 与 Siglec-6 的结合旨在激活受体的天然抑制功能，从而减少肥大细胞的激活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719010014941f862b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719010014941f862b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALLK","BK4139"],"gpt_icon":0},{"id":"2451954556","title":"Allakos Inc.盘中异动 大幅跳水5.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451954556","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451954556?lang=zh_cn&edition=full","pubTime":"2024-07-13 00:44","pubTimestamp":1720802695,"startTime":"0","endTime":"0","summary":"北京时间2024年07月13日00时44分，Allakos Inc.股票出现波动，股价快速跳水5.73%。截至发稿，该股报0.831美元/股，成交量9.1035万股，换手率0.10%，振幅5.89%。Allakos Inc.股票所在的生物技术行业中，整体涨幅为1.40%。Allakos Inc.公司简介：Allakos Inc是一家临床阶段的公司，开发选择性靶向存在于涉及过敏、炎症和增殖性疾病的免疫效应细胞表面的免疫调节受体的治疗性抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240713004456aef97ed2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240713004456aef97ed2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALLK","BK4139"],"gpt_icon":0},{"id":"2450684903","title":"Allakos Inc.盘中异动 股价大涨6.14%报0.881美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450684903","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450684903?lang=zh_cn&edition=full","pubTime":"2024-07-11 21:42","pubTimestamp":1720705351,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日21时42分，Allakos Inc.股票出现波动，股价大幅上涨6.14%。截至发稿，该股报0.881美元/股，成交量5.9164万股，换手率0.07%，振幅3.11%。Allakos Inc.股票所在的生物技术行业中，整体跌幅为0.07%。Allakos Inc.公司简介：Allakos Inc是一家临床阶段的公司，开发选择性靶向存在于涉及过敏、炎症和增殖性疾病的免疫效应细胞表面的免疫调节受体的治疗性抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711214231aef93d71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711214231aef93d71&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALLK"],"gpt_icon":0},{"id":"2450359073","title":"Allakos Inc.盘中异动 股价大涨5.24%报0.807美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450359073","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450359073?lang=zh_cn&edition=full","pubTime":"2024-07-10 00:44","pubTimestamp":1720543459,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日00时44分，Allakos Inc.股票出现异动，股价快速上涨5.24%。截至发稿，该股报0.807美元/股，成交量13.4319万股，换手率0.15%，振幅4.51%。Allakos Inc.股票所在的生物技术行业中，整体跌幅为0.25%。Allakos Inc.公司简介：Allakos Inc是一家临床阶段的公司，开发选择性靶向存在于涉及过敏、炎症和增殖性疾病的免疫效应细胞表面的免疫调节受体的治疗性抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710004419af915ff7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710004419af915ff7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALLK","BK4139"],"gpt_icon":0},{"id":"2450087836","title":"Allakos Inc.盘中异动 临近收盘股价大涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450087836","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450087836?lang=zh_cn&edition=full","pubTime":"2024-07-09 03:56","pubTimestamp":1720468596,"startTime":"0","endTime":"0","summary":"北京时间2024年07月09日03时56分，Allakos Inc.股票出现波动，股价急速上涨5.13%。截至发稿，该股报0.770美元/股，成交量37.5381万股，换手率0.42%，振幅5.28%。Allakos Inc.股票所在的生物技术行业中，整体涨幅为0.81%。Allakos Inc.公司简介：Allakos Inc是一家临床阶段的公司，开发选择性靶向存在于涉及过敏、炎症和增殖性疾病的免疫效应细胞表面的免疫调节受体的治疗性抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407090356369681ab66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407090356369681ab66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALLK"],"gpt_icon":0},{"id":"2449297474","title":"Allakos Inc.盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449297474","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449297474?lang=zh_cn&edition=full","pubTime":"2024-07-06 00:44","pubTimestamp":1720197867,"startTime":"0","endTime":"0","summary":"北京时间2024年07月06日00时44分，Allakos Inc.股票出现异动，股价急速下跌5.00%。截至发稿，该股报0.722美元/股，成交量25.0621万股，换手率0.28%，振幅6.22%。Allakos Inc.股票所在的生物技术行业中，整体涨幅为1.27%。Allakos Inc.公司简介：Allakos Inc是一家临床阶段的公司，开发选择性靶向存在于涉及过敏、炎症和增殖性疾病的免疫效应细胞表面的免疫调节受体的治疗性抗体。AK006 与 Siglec-6 的结合旨在激活受体的天然抑制功能，从而减少肥大细胞的激活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407060044279681a319&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407060044279681a319&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALLK"],"gpt_icon":0},{"id":"2448043894","title":"Allakos Inc.盘中异动 快速跳水5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448043894","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448043894?lang=zh_cn&edition=full","pubTime":"2024-07-04 00:51","pubTimestamp":1720025516,"startTime":"0","endTime":"0","summary":"北京时间2024年07月04日00时51分，Allakos Inc.股票出现异动，股价大幅下跌5.53%。截至发稿，该股报0.794美元/股，成交量25.3739万股，换手率0.29%，振幅9.49%。Allakos Inc.股票所在的生物技术行业中，整体跌幅为1.88%。Allakos Inc.公司简介：Allakos Inc是一家临床阶段的公司，开发选择性靶向存在于涉及过敏、炎症和增殖性疾病的免疫效应细胞表面的免疫调节受体的治疗性抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070400515696819416&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070400515696819416&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALLK"],"gpt_icon":0},{"id":"2448916803","title":"Allakos Inc.盘中异动 股价大跌5.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448916803","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448916803?lang=zh_cn&edition=full","pubTime":"2024-07-01 22:05","pubTimestamp":1719842758,"startTime":"0","endTime":"0","summary":"北京时间2024年07月01日22时05分，Allakos Inc.股票出现波动，股价大幅跳水5.95%。截至发稿，该股报0.941美元/股，成交量11.4659万股，换手率0.13%，振幅6.00%。Allakos Inc.股票所在的生物技术行业中，整体涨幅为0.55%。Allakos Inc.公司简介：Allakos Inc是一家临床阶段的公司，开发选择性靶向存在于涉及过敏、炎症和增殖性疾病的免疫效应细胞表面的免疫调节受体的治疗性抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701220558aef76eab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701220558aef76eab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALLK","BK4139"],"gpt_icon":0},{"id":"2446900684","title":"Allakos Inc.盘中异动 早盘股价大跌5.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446900684","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446900684?lang=zh_cn&edition=full","pubTime":"2024-06-28 23:01","pubTimestamp":1719586913,"startTime":"0","endTime":"0","summary":"北京时间2024年06月28日23时01分，Allakos Inc.股票出现异动，股价快速下跌5.66%。Allakos Inc.股票所在的生物技术行业中，整体跌幅为0.29%。Allakos Inc.公司简介：Allakos Inc是一家临床阶段的公司，开发选择性靶向存在于涉及过敏、炎症和增殖性疾病的免疫效应细胞表面的免疫调节受体的治疗性抗体。消息层面，截至23时01分，《JMP Securities维持Allakos买入评级，维持目标价3美元》资讯为影响Allakos Inc.的重要信息。根据TipRanks数据显示，该分析师近一年总胜率为42.7%，总平均回报率为5.9%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628230154aef72c34&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628230154aef72c34&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALLK"],"gpt_icon":0},{"id":"2446055677","title":"Allakos Inc.盘中异动 股价大跌5.19%报1.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446055677","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446055677?lang=zh_cn&edition=full","pubTime":"2024-06-27 22:29","pubTimestamp":1719498596,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日22时29分，Allakos Inc.股票出现异动，股价快速跳水5.19%。截至发稿，该股报1.01美元/股，成交量7.6679万股，换手率0.09%，振幅4.72%。Allakos Inc.股票所在的生物技术行业中，整体跌幅为0.30%。Allakos Inc.公司简介：Allakos Inc是一家临床阶段的公司，开发选择性靶向存在于涉及过敏、炎症和增殖性疾病的免疫效应细胞表面的免疫调节受体的治疗性抗体。消息层面，截至22时29分，《JMP Securities维持Allakos买入评级，维持目标价3美元》资讯为影响Allakos Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062722295696817878&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062722295696817878&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALLK"],"gpt_icon":0},{"id":"2446139634","title":"Allakos Inc.盘中异动 股价大跌5.93%报1.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446139634","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446139634?lang=zh_cn&edition=full","pubTime":"2024-06-26 21:32","pubTimestamp":1719408733,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日21时32分，Allakos Inc.股票出现波动，股价大幅下跌5.93%。截至发稿，该股报1.11美元/股，成交量6.126万股，换手率0.07%，振幅1.69%。Allakos Inc.股票所在的生物技术行业中，整体跌幅为0.62%。Allakos Inc.公司简介：Allakos Inc是一家临床阶段的公司，开发选择性靶向存在于涉及过敏、炎症和增殖性疾病的免疫效应细胞表面的免疫调节受体的治疗性抗体。消息层面，截至21时32分，《JMP Securities维持Allakos买入评级，维持目标价3美元》资讯为影响Allakos Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406262132139f67f2b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406262132139f67f2b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALLK"],"gpt_icon":0},{"id":"2445006813","title":"Allakos Inc.盘中异动 早盘股价大涨5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2445006813","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445006813?lang=zh_cn&edition=full","pubTime":"2024-06-24 23:13","pubTimestamp":1719242008,"startTime":"0","endTime":"0","summary":"北京时间2024年06月24日23时13分，Allakos Inc.股票出现波动，股价大幅拉升5.41%。截至发稿，该股报1.17美元/股，成交量8.3844万股，换手率0.09%，振幅5.41%。Allakos Inc.股票所在的生物技术行业中，整体涨幅为1.80%。Allakos Inc.公司简介：Allakos Inc是一家临床阶段的公司，开发选择性靶向存在于涉及过敏、炎症和增殖性疾病的免疫效应细胞表面的免疫调节受体的治疗性抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624231329af8eeef6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624231329af8eeef6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALLK"],"gpt_icon":0},{"id":"2445241107","title":"Allakos Inc.盘中异动 股价大跌5.36%报1.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445241107","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445241107?lang=zh_cn&edition=full","pubTime":"2024-06-21 00:10","pubTimestamp":1718899815,"startTime":"0","endTime":"0","summary":"北京时间2024年06月21日00时10分，Allakos Inc.股票出现异动，股价急速下跌5.36%。截至发稿，该股报1.06美元/股，成交量15.4525万股，换手率0.17%，振幅4.46%。Allakos Inc.股票所在的生物技术行业中，整体跌幅为0.32%。Allakos Inc.公司简介：Allakos Inc是一家临床阶段的公司，开发选择性靶向存在于涉及过敏、炎症和增殖性疾病的免疫效应细胞表面的免疫调节受体的治疗性抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406210010159681588b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406210010159681588b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALLK"],"gpt_icon":0},{"id":"2444435288","title":"Allakos Inc.盘中异动 早盘股价大跌5.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444435288","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444435288?lang=zh_cn&edition=full","pubTime":"2024-06-18 21:55","pubTimestamp":1718718950,"startTime":"0","endTime":"0","summary":"北京时间2024年06月18日21时55分，Allakos Inc.股票出现波动，股价快速下挫5.98%。截至发稿，该股报1.10美元/股，成交量1.1722万股，换手率0.01%，振幅3.42%。Allakos Inc.股票所在的生物技术行业中，整体涨幅为0.24%。Allakos Inc.公司简介：Allakos Inc是一家临床阶段的公司，开发选择性靶向存在于涉及过敏、炎症和增殖性疾病的免疫效应细胞表面的免疫调节受体的治疗性抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240618215550aef57948&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240618215550aef57948&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALLK","BK4139"],"gpt_icon":0},{"id":"2443639712","title":"Allakos Inc.盘中异动 快速下挫5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443639712","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443639712?lang=zh_cn&edition=full","pubTime":"2024-06-14 01:16","pubTimestamp":1718298973,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日01时16分，Allakos Inc.股票出现波动，股价急速下跌5.47%。截至发稿，该股报1.21美元/股，成交量29.1955万股，换手率0.33%，振幅4.30%。Allakos Inc.股票所在的生物技术行业中，整体跌幅为0.10%。Allakos Inc.公司简介：Allakos Inc是一家临床阶段的公司，开发选择性靶向存在于涉及过敏、炎症和增殖性疾病的免疫效应细胞表面的免疫调节受体的治疗性抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614011614941ee693&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614011614941ee693&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALLK"],"gpt_icon":0},{"id":"2442285998","title":"Allakos Inc.盘中异动 急速上涨5.17%报1.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442285998","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442285998?lang=zh_cn&edition=full","pubTime":"2024-06-10 22:54","pubTimestamp":1718031248,"startTime":"0","endTime":"0","summary":"北京时间2024年06月10日22时54分，Allakos Inc.股票出现异动，股价大幅上涨5.17%。截至发稿，该股报1.22美元/股，成交量15.9568万股，换手率0.18%，振幅5.27%。Allakos Inc.股票所在的生物技术行业中，整体跌幅为0.15%。Allakos Inc.公司简介：Allakos Inc是一家临床阶段的公司，开发选择性靶向存在于涉及过敏、炎症和增殖性疾病的免疫效应细胞表面的免疫调节受体的治疗性抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240610225408aef42c6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240610225408aef42c6a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALLK","BK4139"],"gpt_icon":0},{"id":"2441399747","title":"Allakos Inc.盘中异动 股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441399747","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441399747?lang=zh_cn&edition=full","pubTime":"2024-06-07 00:48","pubTimestamp":1717692500,"startTime":"0","endTime":"0","summary":"北京时间2024年06月07日00时48分，Allakos Inc.股票出现异动，股价大幅下挫5.04%。截至发稿，该股报1.13美元/股，成交量29.7168万股，换手率0.34%，振幅3.36%。Allakos Inc.股票所在的生物技术行业中，整体涨幅为0.39%。Allakos Inc.公司简介：Allakos Inc是一家临床阶段的公司，开发选择性靶向存在于涉及过敏、炎症和增殖性疾病的免疫效应细胞表面的免疫调节受体的治疗性抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060700482196812a63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060700482196812a63&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALLK"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.allakos.com","stockEarnings":[{"period":"1week","weight":-0.1264},{"period":"1month","weight":-0.3208},{"period":"3month","weight":-0.282},{"period":"6month","weight":-0.3501},{"period":"1year","weight":-0.8439},{"period":"ytd","weight":-0.7238}],"compareEarnings":[{"period":"1week","weight":-0.0123},{"period":"1month","weight":0.0186},{"period":"3month","weight":0.0969},{"period":"6month","weight":0.1427},{"period":"1year","weight":0.2266},{"period":"ytd","weight":0.1669}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Allakos Inc.于2012年3月在特拉华州注册成立。该公司是一家临床阶段生物技术公司，开发AK002，它们是完全拥有的单克隆抗体，用于治疗各种嗜酸性粒细胞和肥大细胞相关疾病。 AK002在完成阶段1试验和单次递增剂量阶段1试验（涉及无痛全身性肥大细胞增多症（“ISM”）的患者）中证明了药效学活性，患者报告其症状得到改善。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.248014},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.072416},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.117765},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.025548},{"month":5,"riseRate":0.333333,"avgChangeRate":0.012634},{"month":6,"riseRate":0.5,"avgChangeRate":-0.038115},{"month":7,"riseRate":0.5,"avgChangeRate":-0.033525},{"month":8,"riseRate":0.666667,"avgChangeRate":0.307937},{"month":9,"riseRate":0.5,"avgChangeRate":0.032321},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.023477},{"month":11,"riseRate":0.833333,"avgChangeRate":0.180786},{"month":12,"riseRate":0.666667,"avgChangeRate":-0.070932}],"exchange":"NASDAQ","name":"Allakos Inc.","nameEN":"Allakos Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Allakos Inc.(ALLK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Allakos Inc.(ALLK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Allakos Inc.,ALLK,Allakos Inc.股票,Allakos Inc.股票老虎,Allakos Inc.股票老虎国际,Allakos Inc.行情,Allakos Inc.股票行情,Allakos Inc.股价,Allakos Inc.股市,Allakos Inc.股票价格,Allakos Inc.股票交易,Allakos Inc.股票购买,Allakos Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Allakos Inc.(ALLK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Allakos Inc.(ALLK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}